BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37964214)

  • 1. Personalized surveillance and aftercare for non-metastasized breast cancer: the NABOR study protocol of a multiple interrupted time series design.
    Klaassen-Dekker A; Drossaert CHC; Van Maaren MC; Van Leeuwen-Stok AE; Retel VP; Korevaar JC; Siesling S;
    BMC Cancer; 2023 Nov; 23(1):1112. PubMed ID: 37964214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and implementation of SHared decision-making supported by OUTcome information among patients with breast cancer, stroke and advanced kidney disease: SHOUT study protocol of multiple interrupted time series.
    Hackert MQN; Ankersmid JW; Engels N; Prick JCM; Teerenstra S; Siesling S; Drossaert CHC; Strobbe LJA; van Riet YEA; van den Dorpel RMA; Bos WJW; van der Nat PB; van den Berg-Vos RM; van Schaik SM; Garvelink MM; van der Wees PJ; van Uden-Kraan CF;
    BMJ Open; 2022 Aug; 12(8):e055324. PubMed ID: 35914919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study protocol of a prospective multicenter study comparing (cost-)effectiveness of a tailored interdisciplinary head and neck rehabilitation program to usual supportive care for patients treated with concomitant chemo- or bioradiotherapy.
    Beck ACC; Passchier E; Retèl VP; Stuiver MM; van der Molen L; Klop WMC; Navran A; van Harten WH; van den Brekel MWM
    BMC Cancer; 2019 Jul; 19(1):655. PubMed ID: 31269918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of the PROstate cancer follow-up care in Secondary and Primary hEalth Care study (PROSPEC): a randomized controlled trial to evaluate the effectiveness of primary care-based follow-up of localized prostate cancer survivors.
    Wollersheim BM; van Asselt KM; van der Poel HG; van Weert HCPM; Hauptmann M; Retèl VP; Aaronson NK; van de Poll-Franse LV; Boekhout AH
    BMC Cancer; 2020 Jul; 20(1):635. PubMed ID: 32641023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effectiveness of personalised surveillance and aftercare in breast cancer follow-up: a systematic review.
    van Maaren MC; van Hoeve JC; Korevaar JC; van Hezewijk M; Siemerink EJM; Zeillemaker AM; Klaassen-Dekker A; van Uden DJP; Volders JH; Drossaert CHC; Siesling S;
    Support Care Cancer; 2024 May; 32(5):323. PubMed ID: 38695938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving the quality and efficiency of follow-up after curative treatment for breast cancer--rationale and study design of the MaCare trial.
    Kimman ML; Voogd AC; Dirksen CD; Falger P; Hupperets P; Keymeulen K; Hebly M; Dehing C; Lambin P; Boersma LJ
    BMC Cancer; 2007 Jan; 7():1. PubMed ID: 17199887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective observational study to assess clinical decision-making, prognosis, quality of life and satisfaction with care in patients with relapsed/refractory multiple myeloma: the CLARITY study protocol.
    Efficace F; Boccadoro M; Palumbo A; Petrucci MT; Cottone F; Cannella L; Zamagni E; Niscola P; Kyriakou C; Caravita T; Offidani M; Mandelli F; Cavo M
    Health Qual Life Outcomes; 2018 Jun; 16(1):127. PubMed ID: 29914509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developing an aftercare decision aid; assessing health professionals' and patients' preferences.
    Klaassen L; Dirksen C; Boersma L; Hoving C;
    Eur J Cancer Care (Engl); 2018 Mar; 27(2):e12730. PubMed ID: 28727259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study protocol of the CAREST-trial: a randomised controlled trial on the (cost-) effectiveness of a CBT-based online self-help training for fear of cancer recurrence in women with curatively treated breast cancer.
    van Helmondt SJ; van der Lee ML; de Vries J
    BMC Cancer; 2016 Jul; 16():527. PubMed ID: 27455846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supporting Shared Decision-making About Surveillance After Breast Cancer With Personalized Recurrence Risk Calculations: Development of a Patient Decision Aid Using the International Patient Decision AIDS Standards Development Process in Combination With a Mixed Methods Design.
    Ankersmid JW; Siesling S; Strobbe LJA; Meulepas JM; van Riet YEA; Engels N; Prick JCM; The R; Takahashi A; Velting M; van Uden-Kraan CF; Drossaert CHC
    JMIR Cancer; 2022 Nov; 8(4):e38088. PubMed ID: 36374536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nationwide implementation of personalized outcomes forecasts to support physical therapists in treating patients with intermittent claudication: Protocol for an interrupted time series study.
    Sinnige A; Kittelson A; Rutgers KM; Marcellis LHM; van der Wees PJ; Teijink JAW; Hoogeboom TJ
    PLoS One; 2023; 18(7):e0288511. PubMed ID: 37523366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ENdometrial cancer SURvivors' follow-up carE (ENSURE): Less is more? Evaluating patient satisfaction and cost-effectiveness of a reduced follow-up schedule: study protocol of a randomized controlled trial.
    Ezendam NPM; de Rooij BH; Kruitwagen RFPM; Creutzberg CL; van Loon I; Boll D; Vos MC; van de Poll-Franse LV
    Trials; 2018 Apr; 19(1):227. PubMed ID: 29661218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised controlled trial protocol (GRIP study): examining the effect of involvement of a general practitioner and home care oncology nurse after a cancer diagnosis on patient reported outcomes and healthcare utilization.
    Perfors IAA; Helsper CW; Noteboom EA; van der Wall E; de Wit NJ; May AM
    BMC Cancer; 2018 Feb; 18(1):132. PubMed ID: 29402234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter study investigating the molecular fingerprint of psychological resilience in breast cancer patients: study protocol of the SCAN-B resilience study.
    Axelsson U; Rydén L; Johnsson P; Edén P; Månsson J; Hallberg IR; Borrebaeck CAK
    BMC Cancer; 2018 Aug; 18(1):789. PubMed ID: 30081937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Home-based multidimensional survivorship programmes for breast cancer survivors.
    Cheng KKF; Lim YTE; Koh ZM; Tam WWS
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD011152. PubMed ID: 28836379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opportunities for personalised follow-up care among patients with breast cancer: A scoping review to identify preference-sensitive decisions.
    de Ligt KM; van Egdom LSE; Koppert LB; Siesling S; van Til JA
    Eur J Cancer Care (Engl); 2019 May; 28(3):e13092. PubMed ID: 31074162
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.